CHINA TO PROVIDE JAPANESE ENCEPHALITIS VACCINE FOR CHILDREN OF APPROPRIATE AGE IN TIBET, QINGHAI, XINJIANG
IZMO:
CO SAYS THE CAPABILITY HAS APPLICATIONS ACROSS RADAR, ELECTRONIC WARFARE, SECURE COMMUNICATIONS, AEROSPACE, SATELLITE COMMUNICATIONS AND ADVANCED WIRELESS SYSTEMS
CO SAYS THE CAPABILITY HAS APPLICATIONS ACROSS RADAR, ELECTRONIC WARFARE, SECURE COMMUNICATIONS, AEROSPACE, SATELLITE COMMUNICATIONS AND ADVANCED WIRELESS SYSTEMS
❤1
COAL INDIA: AUGUST PRODUCTION DOWN 5.7% YoY
• Aug 2026 production fell 5.7% YoY to 47.5 MT vs 50.4 MT.
• Coal offtake rose 5.5% YoY to 60.6 MT.
• Apr–Aug FY27 production down 4.5% YoY to 267.5 MT.
• Apr–Aug cumulative offtake up 6.7% YoY to 322.9 MT.
• ECL, CCL & WCL reported strong production growth, while NCL, SECL & MCL declined.
• Aug 2026 production fell 5.7% YoY to 47.5 MT vs 50.4 MT.
• Coal offtake rose 5.5% YoY to 60.6 MT.
• Apr–Aug FY27 production down 4.5% YoY to 267.5 MT.
• Apr–Aug cumulative offtake up 6.7% YoY to 322.9 MT.
• ECL, CCL & WCL reported strong production growth, while NCL, SECL & MCL declined.
TATA MOTORS CV: AUG SALES UP 49% YoY TO 44,411
• Total CV sales at 44,411 units vs 29,863 last year; above estimate of 38,800.
• Domestic CV sales up 33% YoY to 36,619 units.
• International sales surged 227% YoY to 7,792 units.
• HCV truck sales rose 42%, while SCV cargo & pickups grew 34%.
• Passenger carrier sales increased 31% YoY to 4,701 units.
• Domestic MH&ICV sales up 31% YoY to 17,531 units.
• Total CV sales at 44,411 units vs 29,863 last year; above estimate of 38,800.
• Domestic CV sales up 33% YoY to 36,619 units.
• International sales surged 227% YoY to 7,792 units.
• HCV truck sales rose 42%, while SCV cargo & pickups grew 34%.
• Passenger carrier sales increased 31% YoY to 4,701 units.
• Domestic MH&ICV sales up 31% YoY to 17,531 units.
INDIA AUG. GST COLLECTIONS RUPEES 1.99T VS 1.74T (YOY) || AUG. GST COLLECTIONS RISE 14.8% YOY
INDIA AUG. GST COLLECTIONS RUPEES 1.99T || AUG. GST COLLECTIONS RISE 14.8% YOY
❤2
TATA ELXSI: CO. AND SARLA AVIATION PARTNER TO ACCELERATE DEVELOPMENT OF SHUNYA, INDIA''S FIRST INDIGENOUS EVTOL AIRCRAFT".
SAKAR HEALTHCARE: CO RECEIVES 14 ONCOLOGY PRODUCT NEW APPROVALS IN THE EU (EUROPE), UK AND CANADA WITH 7 BUSINESS PARTNERS
MARUTI SUZUKI: AUGUST TOTAL SALES RISE 21% YoY TO 2.19 LAKH UNITS 🚀
🚗 Total sales increased 21.3% YoY to 2,19,220 units in August 2026 vs 1,80,683 units.
🇮🇳 Domestic sales including LCV surged 34.3% YoY to 1,80,078 units.
🚙 Domestic passenger vehicle sales jumped 34.8% YoY to 1,76,971 units.
🔥 Utility vehicle sales rose 46.3% YoY to 79,045 units, while passenger car sales increased 29.4% to 85,965 units.
🌍 Exports declined 7.4% YoY to 33,844 units, while sales to other OEMs fell to 5,298 units from 10,095 units.
📈 Apr–Aug FY27 total sales reached 11.43 lakh units, up 28.6% YoY, crossing the 1 million-unit milestone within the first five months of FY27.
🚗 Total sales increased 21.3% YoY to 2,19,220 units in August 2026 vs 1,80,683 units.
🇮🇳 Domestic sales including LCV surged 34.3% YoY to 1,80,078 units.
🚙 Domestic passenger vehicle sales jumped 34.8% YoY to 1,76,971 units.
🔥 Utility vehicle sales rose 46.3% YoY to 79,045 units, while passenger car sales increased 29.4% to 85,965 units.
🌍 Exports declined 7.4% YoY to 33,844 units, while sales to other OEMs fell to 5,298 units from 10,095 units.
📈 Apr–Aug FY27 total sales reached 11.43 lakh units, up 28.6% YoY, crossing the 1 million-unit milestone within the first five months of FY27.
EICHER MOTORS AUGUST MOTORCYCLE SALES UP 11% YoY TO 1.26 LAKH UNITS
• Total motorcycle sales: 1,26,479 units vs 1,14,002 — +11% YoY
• Up to 350cc & EV sales: 1,13,143 units — +15% YoY
• Above 350cc sales: 13,336 units — -13% YoY
• International business sales: 12,275 units — +10% YoY
• Apr–Aug FY27 total sales: 5,75,138 units — +23% YoY
• YTD up to 350cc sales grew 28%, while above 350cc declined 5%.
• August sales came in at 1.26 lakh units vs ~1.25 lakh estimated.
• Total motorcycle sales: 1,26,479 units vs 1,14,002 — +11% YoY
• Up to 350cc & EV sales: 1,13,143 units — +15% YoY
• Above 350cc sales: 13,336 units — -13% YoY
• International business sales: 12,275 units — +10% YoY
• Apr–Aug FY27 total sales: 5,75,138 units — +23% YoY
• YTD up to 350cc sales grew 28%, while above 350cc declined 5%.
• August sales came in at 1.26 lakh units vs ~1.25 lakh estimated.
DGFT AUTOMATES ISSUANCE OF FREE SALE & COMMERCE CERTIFICATES FOR EXPORTERS
Eligible FSC applications to be auto-approved on DGFT portal
Move aimed at easing compliance burden for exporters
Applications needing verification will be sent for manual scrutiny
DGFT to use risk-based checks; certificates can be flagged for review
FSCs issued for items not covered under Drugs & Cosmetics Act, 1940
Source PIB
Eligible FSC applications to be auto-approved on DGFT portal
Move aimed at easing compliance burden for exporters
Applications needing verification will be sent for manual scrutiny
DGFT to use risk-based checks; certificates can be flagged for review
FSCs issued for items not covered under Drugs & Cosmetics Act, 1940
Source PIB
LIC likely to raise Stake in NSE by, Up to 1% Post-Listing
LIC may buy 0.5-1% stake in NSE on the listing day
Purchase size will depend on NSE's listing valuation, & prevailing market conditions
LIC has opted not to sell its existing NSE stake in the IPO, in line with its long-term strategy
LIC may buy 0.5-1% stake in NSE on the listing day
Purchase size will depend on NSE's listing valuation, & prevailing market conditions
LIC has opted not to sell its existing NSE stake in the IPO, in line with its long-term strategy
GRAVITY INDIA APPROVES ₹90 CR QIP & EXPANDS BUSINESS OBJECTS
• Board approved a QIP to raise up to ₹90 Cr.
• Funds to be used for working capital and general corporate purposes, capped at 25%.
• Company plans to amend its MOA to include IT services, data centres and semiconductor businesses.
• 39th AGM scheduled for September 25, 2026.
• Record date: September 18, 2026; book closure: September 19–25, 2026.
• Ms. Arvind Sudra & Associates appointed as scrutinizer for the AGM.
• Board approved a QIP to raise up to ₹90 Cr.
• Funds to be used for working capital and general corporate purposes, capped at 25%.
• Company plans to amend its MOA to include IT services, data centres and semiconductor businesses.
• 39th AGM scheduled for September 25, 2026.
• Record date: September 18, 2026; book closure: September 19–25, 2026.
• Ms. Arvind Sudra & Associates appointed as scrutinizer for the AGM.
UNACADEMY CEO ON X
Unacademy Acquisition By UpGrad Closes At Just Over $200 Mn
We Raised At A Peak, But Sold At A Fraction Of That
Unacademy Mission Was To Democratise Education
Unacademy's Free Platform Created A Generation Of Celebrity Educators
₹400 Cr Topline, ₹900 Cr Cash; Chose UpGrad Deal Over Independence
Four ESOP Buybacks Created Real Value For Employees
Unacademy Acquisition By UpGrad Closes At Just Over $200 Mn
We Raised At A Peak, But Sold At A Fraction Of That
Unacademy Mission Was To Democratise Education
Unacademy's Free Platform Created A Generation Of Celebrity Educators
₹400 Cr Topline, ₹900 Cr Cash; Chose UpGrad Deal Over Independence
Four ESOP Buybacks Created Real Value For Employees
BONDADA ENGINEERING: CO FILES FOR MAIN BOARD MIGRATION, REPORTS ₹10,023 CRORE ORDER BOOK AND EXPANDS DEFENCE BUSINESS WITH SUBSIDIARY’S ₹2.10 CRORE ORDER BOOK
❤1👍1
NUVAMA ON SHILPA MEDICARE ;
INITIATES BUY | TP ₹1,200
• Values stock at 40x Sep-28E EPS.
• Estimates Revenue / EBITDA / PAT CAGR of 25% / 33% / 39% over FY26–29E.
• Formulations & biologics could contribute ~60% of revenue by FY29E, driven by key product launches.
• After aggressive capex, Shilpa Medicare has entered the monetisation phase.
• Growing CDMO pipeline and rHA-Albumin commercialisation provide growth visibility beyond FY29E.
INITIATES BUY | TP ₹1,200
• Values stock at 40x Sep-28E EPS.
• Estimates Revenue / EBITDA / PAT CAGR of 25% / 33% / 39% over FY26–29E.
• Formulations & biologics could contribute ~60% of revenue by FY29E, driven by key product launches.
• After aggressive capex, Shilpa Medicare has entered the monetisation phase.
• Growing CDMO pipeline and rHA-Albumin commercialisation provide growth visibility beyond FY29E.
❤1